Recombinant Human CD14 protein is a Human Fragment protein, in the 20 to 335 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, MS, HPLC.
>=95% SDS-PAGE
<= 0.005 EU/µg
HEK 293 cells
Tag free
SDS-PAGE, MS, HPLC
No
T T P E P C E L D D E D F R C V C N F S E P Q P D W S E A F Q C V S A V E V E I H A G G L N L E P F L K R V D A D A D P R Q Y A D T V K A L R V R R L T V G A A Q V P A Q L L V G A L R V L A Y S R L K E L T L E D L K I T G T M P P L P L E A T G L A L S S L R L R N V S W A T G R S W L A E L Q Q W L K P G L K V L S I A Q A H S P A F S Y E Q V R A F P A L T S L D L S D N P G L G E R G L M A A L C P H K F P A I Q N L A L R N T G M E T P T G V C A A L A A A G V Q P H S L D L S H N S L R A T V N P S A P R C M W S S A L N S L N L S F A G L E Q V P K G L P A K L R V L D L S C N R L N R A P Q P D E L P E V D N L T L D G N P F L V P G
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Coreceptor for bacterial lipopolysaccharide (PubMed:1698311, PubMed:23264655). In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed:20133493, PubMed:23264655, PubMed:22265692). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:8612135). Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) (PubMed:23880187).
Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14
Recombinant Human CD14 protein is a Human Fragment protein, in the 20 to 335 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, MS, HPLC.
Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14
>=95% SDS-PAGE
<= 0.005 EU/µg
HEK 293 cells
Tag free
SDS-PAGE, MS, HPLC
No
Yes
Yes
Human
Reconstitute in PBS
pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.428% Potassium phosphate monobasic
T T P E P C E L D D E D F R C V C N F S E P Q P D W S E A F Q C V S A V E V E I H A G G L N L E P F L K R V D A D A D P R Q Y A D T V K A L R V R R L T V G A A Q V P A Q L L V G A L R V L A Y S R L K E L T L E D L K I T G T M P P L P L E A T G L A L S S L R L R N V S W A T G R S W L A E L Q Q W L K P G L K V L S I A Q A H S P A F S Y E Q V R A F P A L T S L D L S D N P G L G E R G L M A A L C P H K F P A I Q N L A L R N T G M E T P T G V C A A L A A A G V Q P H S L D L S H N S L R A T V N P S A P R C M W S S A L N S L N L S F A G L E Q V P K G L P A K L R V L D L S C N R L N R A P Q P D E L P E V D N L T L D G N P F L V P G
Fragment
34.24 kDa
34.24 kDa
20 to 335
Recombinant
Lyophilized
>95% by HPLC
Coreceptor for bacterial lipopolysaccharide (PubMed:1698311, PubMed:23264655). In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed:20133493, PubMed:23264655, PubMed:22265692). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:8612135). Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) (PubMed:23880187).
N- and O- glycosylated. O-glycosylated with a core 1 or possibly core 8 glycan.
Ambient - Can Ship with Ice
Ambient
CD14 also known as cluster of differentiation 14 is a glycoprotein with a molecular mass of approximately 55 kDa. This protein is expressed mainly on the surface of macrophages monocytes and to a lesser extent on neutrophils. CD14 exists in two forms: membrane-bound (mCD14) and soluble (sCD14). It functions as a co-receptor along with TLR4 (Toll-like receptor 4) and MD-2 for the detection of bacterial lipopolysaccharide (LPS) which is an important component of the outer membrane of Gram-negative bacteria.
This glycoprotein plays a significant role in the innate immune system by recognizing pathogen-associated molecular patterns (PAMPs). It is part of a receptor complex where CD14 acts alongside LPS binding protein (LPS-R) TLR4 and MD-2 to facilitate pro-inflammatory signaling in response to microbial invasion. By binding to LPS CD14 initiates and amplifies the immune response leading to the production of cytokines and the recruitment of other immune cells to the site of infection.
CD14 interacts with the toll-like receptor signaling pathway notably involving TLR4. Upon LPS detection CD14 assists in the activation of TLR4 triggering downstream signaling cascades such as NF-κB and MAPK pathways. These pathways result in the transcription of inflammatory cytokines and are essential for the host defense mechanism. The protein complex involving CD14 further interacts with adaptor proteins like MyD88 and TRIF facilitating signal propagation and the immune system's ability to respond to pathogens.
Researchers have linked CD14 to sepsis and atherosclerosis. High levels of soluble CD14 (sCD14) are often observed in patients with sepsis indicating its participation in excessive systemic inflammation. In atherosclerosis CD14's role in recognizing LPS contributes to chronic inflammation and the development of plaques in arteries. Through these diseases CD14 connects with TLR4 emphasizing its impact on inflammatory responses and its potential as a therapeutic target.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
SDS-PAGE analysis of ab282377.
Mass determination by ESI-TOF.
Predicted MW is 34238.23 Da (+/- 10 Da by ESI-TOF). Observed MW is 34241.39 Da.
HPLC analysis of ab282377.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com